Mechanisms and disease consequences of nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is the leading chronic liver disease worldwide. Its
more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver …
more advanced subtype, nonalcoholic steatohepatitis (NASH), connotes progressive liver …
Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
X Xu, KL Poulsen, L Wu, S Liu, T Miyata… - Signal transduction and …, 2022 - nature.com
Non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) has become the leading
cause of liver disease worldwide. NASH, an advanced form of NAFL, can be progressive …
cause of liver disease worldwide. NASH, an advanced form of NAFL, can be progressive …
The role of the microbiome in NAFLD and NASH
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of cardiometabolic
syndrome, which often also includes obesity, diabetes, and dyslipidemia. It is rapidly …
syndrome, which often also includes obesity, diabetes, and dyslipidemia. It is rapidly …
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Hepatic steatosis is a multifactorial condition that is often observed in obese patients and is
a prelude to non-alcoholic fatty liver disease. Here, we combine shotgun sequencing of fecal …
a prelude to non-alcoholic fatty liver disease. Here, we combine shotgun sequencing of fecal …
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
S Lim, JW Kim, G Targher - Trends in Endocrinology & Metabolism, 2021 - cell.com
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a chronic condition
characterized by hepatic fat accumulation combined with underlying metabolic …
characterized by hepatic fat accumulation combined with underlying metabolic …
FGF21: an emerging therapeutic target for non-alcoholic steatohepatitis and related metabolic diseases
EJ Tillman, T Rolph - Frontiers in endocrinology, 2020 - frontiersin.org
The rising global prevalence of obesity, metabolic syndrome, and type 2 diabetes has driven
a sharp increase in non-alcoholic fatty liver disease (NAFLD), characterized by excessive fat …
a sharp increase in non-alcoholic fatty liver disease (NAFLD), characterized by excessive fat …
Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications
J Chen, L Vitetta - International journal of molecular sciences, 2020 - mdpi.com
Gut microbiota dysregulation plays a key role in the pathogenesis of nonalcoholic fatty liver
disease (NAFLD) through its metabolites. Therefore, the restoration of the gut microbiota and …
disease (NAFLD) through its metabolites. Therefore, the restoration of the gut microbiota and …
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related …
Gut microbiota is involved in obesity, metabolic syndrome and the progression of
nonalcoholic fatty liver disease (NAFLD). It has been recently suggested that the flavonoid …
nonalcoholic fatty liver disease (NAFLD). It has been recently suggested that the flavonoid …
Current concepts, opportunities, and challenges of gut microbiome-based personalized medicine in nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NALFD) is now a leading cause of chronic liver disease
worldwide, in part, as a consequence of rapidly rising levels of obesity and metabolic …
worldwide, in part, as a consequence of rapidly rising levels of obesity and metabolic …
Alcohol, inflammation, and microbiota in alcoholic liver disease
M Dukić, T Radonjić, I Jovanović, M Zdravković… - International journal of …, 2023 - mdpi.com
Alcoholic liver disease (ALD) is a consequence of excessive alcohol use. According to many
studies, alcohol represents a significant socioeconomic and health risk factor in today's …
studies, alcohol represents a significant socioeconomic and health risk factor in today's …